/Investor DB

The W Fund

Venture capital

Seattle · Pre-Seed–Series A

Not to be confused with The W Fund (Venture capital · New York, US)

Find your way into The W Fund

Sign up to find every way you can get introduced to The W Fund

  • Your email: who you already know at The W Fund, and who your contacts know
  • 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the The W Fund team
  • Your LinkedIn: the connections who can make the intro for you

We rank every route by how warm it is, so you raise on warm intros instead of cold emails.

✨ Fox Verdict
Sign up to see your fit

Investment thesis

The W Fund supports early-stage technology companies emerging from Washington state's academic and research ecosystem. The fund prioritizes ventures based on intellectual property developed through university research programs and maintains strong connections to faculty and students at institutions including the University of Washington, Washington State University, and affiliated research centers. Investment focus spans life sciences, software, IT, engineering, and clean technology sectors, with typical first checks up to $500,000 in rounds of $1 million or more.

Source: firm website, verified Aug 7, 2026.

Stage
Pre-Seed–Series A
Check
$500K
HQ
Seattle, US
Leads rounds
Follows
Instruments
Equity
AUM
$20M
Tracked investments
19

What they invest in

from 11 of 19 portfolio companies

Biotech ×6Deep Tech ×4Hardware ×4Consumer ×2Healthtech ×2Robotics ×2Advanced Manufacturing ×1AI & Machine Learning ×1

HQs:United States×11

Investments · 19 tracked

founders shown can be your intro path

By year:2018 · 12016 · 12015 · 13 dated

AnswerDashanswerdash.cominAug 2015

Seattle, US

JACOB O. WOBBROCK(Executive Officer)inWILLIAM T. COLLERAN(Executive Officer, Director)ANDREW KO(Executive Officer)

BoardWILLIAM MCALEER(Director)inMARK UPSON(Director)MICHAEL FRIDGEN(Director)

Co-investorsCowles VenturesVoyager CapitalWRF Capital

Athiraathira.com

A biotechnology company developing new therapies for patients with high unmet medical needs.

Biotech

Co-investorsDolby Family VenturesLifeSci Venture PartnersSofinnova VenturesCommodore CapitalFranklin TempletonLigand Pharmaceuticals+5 more

Bellwether BioinApr 2018

BiotechSeattle, US

Rahul Shendure(Executive Officer, Director, Promoter)inMatthew Snyder(Director)

Co-investorsWRF Capital

BlackOakTVblackoak.tvin𝕏SeedDefunct

A subscription video platform that helps Black viewers discover and watch content created by and featuring Black creators and performers.

ConsumerMedia & EntertainmentNew York City, US

Uzo Ometu(Founder)inIyanu Obidele(Founder)in

Co-investorsTechstarsY CombinatorBackstage CapitalBungalow CapitalCresset CapitalGlobal Founders Capital+6 more

Cardiac Insight Inc.cardiacinsightinc.comin𝕏

Cardiac Insight develops handheld and wearable ECG devices for cardiac diagnostics, including the Cardea 20/20 for athlete heart screening and the Cardea SOLO for 7-day ambulatory monitoring.

BiotechHardwareHealthtechMedical DevicesBellevue, US

David Linker(Executive Officer, Director)Dr. Dave Hadley(Founder)Dr. Vic Froelicher(Founder)Bill Willis(Executive Officer)inBrad Harlow(Executive Officer, Director)inRobert deGavre(Executive Officer, Director)

Co-investorsCowles VenturesKeiretsu ForumSeaChange

Cyrus Biotechnologycyrusbio.comin𝕏

Cyrus operates a protein engineering platform that combines AI and Rosetta computational design methods with a biochemistry lab performing large-scale deep mutagenesis scanning, protein stabilization, immunogenicity reduction, and affinity/specificity tuning.

AI & Machine LearningBiotechDeep TechSeattle, US

Yifan Song(CSO)inDavid Baker(Co-founder)Javier Castellanos(Executive Officer, Director)inMark(President & EVP, Business Development)

BoardLucas Nivon(CEO)in

Co-investorsAlumni VenturesAnzu PartnersArgonautic VenturesiSelect FundOrbiMedSPRINGROCK VENTURES+4 more

Exit C-SATScsats.com

CSATS is a Seattle-based healthcare technology company providing AI-driven surgical video capture, analytics and performance feedback.

Seattle, US

Thomas Lendvay(Executive Officer, Director, Promoter)

BoardDerek Streat(Executive Officer, Director, Promoter)Hans Lundin(Director)

Co-investorsHealthtech CapitalSeaChangeSPRINGROCK VENTURES

HyperScienceshypersciences.comin𝕏

HyperSciences develops a hypersonic accelerator engine aimed at mining and tunneling applications.

Construction TechDeep TechHardwareSpokane, US

Mark Russell(Executive Officer, Director)inMichelle Carbon(Executive Officer)in

BoardMichael McSherry(Director)Charles Russell(Director)

Co-investorsCowles VenturesMilkbox Partners

Nexgenianexgeniacorp.com

Nexgenia develops proprietary stimuli-responsive polymer-based reagents for molecular and cellular selection, diagnostics, and immunoassays.

BiotechDeep TechNew MaterialsSeattle, US

Ron Myers(Executive Officer, Director)

BoardSteven Gillis(Director)Charles P. Waite(Director)Martin Simonetti(Director)Stewart Parker(Director)David Urdal(Director)

Co-investorsAlliance of AngelsWRF Capital

Olis Roboticsolisrobotics.comin

Olis Robotics provides remote monitoring, control, and troubleshooting solutions for industrial robots, serving over 50% of the global installed industrial robot fleet.

Advanced ManufacturingDeep TechEnterprise SoftwareRoboticsSeattle, US

Co-investorsAlliance of AngelsPioneer Square LabsSeaChangeTectonic VenturesUbiquity VenturesPSL Ventures

Vicisvicis.com𝕏

VICIS manufactures protective equipment for youth football players, specifically shoulder pads featuring advanced impact protection and lightweight design.

ConsumerHardwareSports Tech

Co-investorsAlliance of Angels

WiBoticwibotic.comin𝕏

WiBotic makes wireless charging hardware and fleet energy management software for robots, drones, and autonomous vehicles, using adaptive antenna tuning to charge across different battery chemistries, voltages, and charging rates.

EnergyHardwareRoboticsSeattle, US

Benjamin Waters(Executive Officer, Director, Promoter)Joshua R Smith(Director)

BoardPingrong Yu(Director)Michael Li(Director)Robert Wetzel(Director)Mark Rogers(Director)

Co-investorsComet LabsWisemont CapitalTsing Capital

Other

Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.

AqueductBeat BiotherapeuticsLumisandsNavisonicsPast CompaniesStasysTwinstrand

Portfolio news

latest coverage across their companies

Frequently asked questions

How many investments has The W Fund made?
The W Fund has 19 tracked investments.
What stage does The W Fund invest at?
The W Fund invests at the Pre-Seed, Seed, Series A stages.
What is The W Fund's typical check size?
The W Fund typically writes checks of $500K.
What sectors does The W Fund focus on?
The W Fund focuses on Biotech, Cleantech, Cloud Computing, Deep Tech, Hardware, Medical Devices, New Materials.
Where is The W Fund located?
The W Fund is headquartered in Seattle, US.
Does The W Fund lead rounds?
The W Fund typically participates in rounds rather than leading them.
Who does The W Fund co-invest with?
The W Fund most often shares deals with Cowles Ventures, SeaChange, SPRINGROCK VENTURES, among 23 tracked co-investors.

Similar investors

Featured in lists